In a move to strengthen its leadership team, pharmacy benefits manager LucyRx has appointed three seasoned executives to spearhead its financial, people, and clinical strategy functions.

The company has named Lankford Wade as President and Chief Financial Officer, Lori Hart as Chief Human Resources Officer, and Lisa Liburd, PharmD, MBA, as Vice President of Clinical Strategy.

With these strategic hires, LucyRx is gearing up to challenge industry norms and put patients at the heart of pharmacy benefits management, the company said.

A financial architect to steer growth

Lankford Wade, a veteran in healthcare financial strategy, steps into the dual role of President and CFO. With more than two decades of experience in driving financial performance and operational excellence, he will guide LucyRx through its next phase of growth.

His track record includes scaling businesses, optimising operations, and ensuring stakeholders see real value – qualities that align perfectly with LucyRx’s ambition to simplify and improve access to prescription care, the company believes.

Wade brings a wealth of experience in financial strategy and operational leadership. The leadership at LucyRx believe his ability to drive efficiency and sustainable growth will be invaluable as the company continues to redefine pharmacy benefits.

Also Read: Diversity is welcome in the pharma industry

People-first leadership for high performance

At the heart of any great organisation is its people, and LucyRx has turned to Lori Hart to shape its workforce strategy.

As the new CHRO, she will oversee talent acquisition, employee engagement, and leadership development, ensuring that LucyRx attracts and retains top talent in a competitive healthcare landscape.

Hart, an expert in scaling organisations and fostering strong workplace cultures, has spent her career leading HR teams across complex corporate structures. Her ability to blend data-driven HR strategies with a human touch will be critical as LucyRx continues to grow.

Hart’s expertise in building dynamic teams and fostering an engaging work environment will help LucyRx maintain its momentum, the company said.

Also Read: How AI is changing HR leadership

A clinical strategist to drive innovation

The appointment of Lisa Liburd as Vice President of Clinical Strategy signals LucyRx’s commitment to pioneering new approaches to pharmacy benefits.

With over 20 years of experience in clinical strategy, formulary management, and utilisation management, Liburd is tasked with developing innovative programmes that enhance affordability and improve health outcomes.

One of her immediate priorities will be designing solutions that provide sustainable access to GLP-1 medications, balancing pharmaceutical care with best-practice protocols in nutrition and lifestyle support. Her leadership will ensure that plan sponsors and members alike receive high-quality, cost-effective care.

Building for the future

LucyRx is positioning itself as a disruptive force in the pharmacy benefits industry, and these leadership appointments reinforce its mission to deliver smarter, patient-centric solutions, the company believes.

With a US$500 million capital investment and an advanced AI-powered analytics platform, LucyRx said it is keeping pace with industry changes.

“Lankford, Lori, and Lisa bring exceptional leadership and deep expertise to LucyRx,” said David Blair, CEO of LucyRx.

“They join our senior leadership team who have decades of experience across healthcare and pharmacy benefits, further positioning LucyRx as a trusted partner to employers and brokers. Their unique strengths will help us execute our strategy, deliver measurable value, and continue creating a simpler, more affordable prescription benefits model.”